Healthtech funding in Q1 2015
European Healthtech startup funding raised during Q1 2015.
In Q1 2015, 35 European Healthtech companies closed 37 funding rounds and raised €182M in equity funding (excluding debt and grants), up 15.5% versus Q1 2014. Debt rounds added €260k. Germany led by capital raised, and BioMedPartners was the most active investor. Data as of 20 Nov 2026.
Equity funding
€182M
+15.5% vs Q1 2014 · excl. debt & grants · +€260k debt
Funding rounds
37
+23.3% vs Q1 2014
Companies
35
Top country
Germany
Rank among sectors
#10
3.7% of sector funding
Debt financing
€260k
0.1% of total
Top-10 round share
82.9%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q1 2015 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €102M | 16 |
| Feb | €873k | 6 |
| Mar | €79M | 15 |
Top countries
by € raisedHealthtech — top countries by capital, Q1 2015 — interactive chart.
Data table
| Healthtech — top countries by capital, Q1 2015 | |
|---|---|
| Germany | €51M |
| Switzerland | €29M |
| Denmark | €23M |
| Ireland | €23M |
| Israel | €21M |
| Italy | €9.3M |
| Austria | €8.8M |
| Sweden | €5.7M |
Stage mix
by € raisedHealthtech — stage mix, Q1 2015 — interactive chart.
Data table
| Healthtech — stage mix, Q1 2015 | |
|---|---|
| Series D+ | €80M |
| Series B | €48M |
| Series A | €28M |
| Seed | €11M |
| Other | €8.6M |
| Early VC | €4.3M |
| Growth/Late | €1.0M |
| Debt | €260k |
Top deals
largest disclosed rounds in Q1 2015| Company | Stage | Date | Amount |
|---|---|---|---|
| CureVac | Series D+ | Mar 2015 | €46M |
| Veryan Medical | Series B | Jan 2015 | €23M |
| Orphazyme | Series B | Jan 2015 | €20M |
| GenKyoTex | Series D+ | Jan 2015 | €17M |
| EarlySense | Series D+ | Jan 2015 | €16M |
| MindMaze | Seed | Mar 2015 | €7.7M |
| Genenta Science | Series A | Jan 2015 | €5.9M |
| MediSafe | Other | Jan 2015 | €4.9M |
| Rigontec | Series A | Mar 2015 | €4.8M |
| TrialBee | Series A | Mar 2015 | €4.5M |
| Miracor Medical Systems | Series B | Jan 2015 | €4.5M |
| MySugr | Series A | Mar 2015 | €4.3M |
| Genenta Science | Series A | Mar 2015 | €3.4M |
| NBE-Therapeutics | Series A | Mar 2015 | €2.8M |
| Sekoia | Early VC | Mar 2015 | €2.7M |
Top investors
most active in Q1 2015, by deal count- BioMedPartners2 deals
- Boehringer Ingelheim Venture Fund2 deals
- Bpifrance2 deals
- Imprimatur Capital2 deals
- Sunstone Capital2 deals
- 7wire Ventures1 deals
- Accelerace1 deals
- Aescap1 deals
- Axel Springer Plug and Play Accelerator1 deals
- BOM Capital - Brabantse Ontwikkelings Maatschappij1 deals